342 related articles for article (PubMed ID: 27725193)
21. Therapeutic approaches for lysosomal storage diseases: a patent update.
Urbanelli L; Sagini K; Polidoro M; Brozzi A; Magini A; Emiliani C
Recent Pat CNS Drug Discov; 2013 Aug; 8(2):91-109. PubMed ID: 23713988
[TBL] [Abstract][Full Text] [Related]
22. Cell and gene-based therapies for the lysosomal storage diseases.
Hodges BL; Cheng SH
Curr Gene Ther; 2006 Apr; 6(2):227-41. PubMed ID: 16611044
[TBL] [Abstract][Full Text] [Related]
23. Gene transfer strategies for correction of lysosomal storage disorders.
D'Azzo A
Acta Haematol; 2003; 110(2-3):71-85. PubMed ID: 14583667
[TBL] [Abstract][Full Text] [Related]
24. Gene therapy for lysosomal storage disorders.
Yew NS; Cheng SH
Pediatr Endocrinol Rev; 2013 Nov; 11 Suppl 1():99-109. PubMed ID: 24380128
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy of lysosomal storage disorders.
Salvetti A; Heard JM; Danos O
Br Med Bull; 1995 Jan; 51(1):106-22. PubMed ID: 7767637
[TBL] [Abstract][Full Text] [Related]
26. A review of gene therapy in canine and feline models of lysosomal storage disorders.
Bradbury AM; Gurda BL; Casal ML; Ponder KP; Vite CH; Haskins ME
Hum Gene Ther Clin Dev; 2015 Mar; 26(1):27-37. PubMed ID: 25671613
[TBL] [Abstract][Full Text] [Related]
27. Neurological manifestations of lysosomal disorders and emerging therapies targeting the CNS.
Giugliani R; Vairo F; Kubaski F; Poswar F; Riegel M; Baldo G; Saute JA
Lancet Child Adolesc Health; 2018 Jan; 2(1):56-68. PubMed ID: 30169196
[TBL] [Abstract][Full Text] [Related]
28. Current treatment options and novel nanotechnology-driven enzyme replacement strategies for lysosomal storage disorders.
Del Grosso A; Parlanti G; Mezzena R; Cecchini M
Adv Drug Deliv Rev; 2022 Sep; 188():114464. PubMed ID: 35878795
[TBL] [Abstract][Full Text] [Related]
29. Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal Diseases.
Holley RJ; Wood SR; Bigger BW
ACS Chem Neurosci; 2019 Jan; 10(1):18-20. PubMed ID: 30136572
[TBL] [Abstract][Full Text] [Related]
30. Stem Cell Applications in Lysosomal Storage Disorders: Progress and Ongoing Challenges.
Köse S; Aerts-Kaya F; Uçkan Çetinkaya D; Korkusuz P
Adv Exp Med Biol; 2021; 1347():135-162. PubMed ID: 33977438
[TBL] [Abstract][Full Text] [Related]
31. Treatment strategies for lysosomal storage disorders.
Beck M
Dev Med Child Neurol; 2018 Jan; 60(1):13-18. PubMed ID: 29090451
[TBL] [Abstract][Full Text] [Related]
32. Enzyme enhancement therapeutics for lysosomal storage diseases: Current status and perspective.
Thomas R; Kermode AR
Mol Genet Metab; 2019 Feb; 126(2):83-97. PubMed ID: 30528228
[TBL] [Abstract][Full Text] [Related]
33. Recent developments in therapeutic approaches for lysosomal storage diseases.
Urbanelli L; Magini A; Polchi A; Polidoro M; Emiliani C
Recent Pat CNS Drug Discov; 2011 Jan; 6(1):1-19. PubMed ID: 21073432
[TBL] [Abstract][Full Text] [Related]
34. Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges.
Desnick RJ; Schuchman EH
Annu Rev Genomics Hum Genet; 2012; 13():307-35. PubMed ID: 22970722
[TBL] [Abstract][Full Text] [Related]
35. Gene therapy for the lysosomal storage disorders.
Cabrera-Salazar MA; Novelli E; Barranger JA
Curr Opin Mol Ther; 2002 Aug; 4(4):349-58. PubMed ID: 12222873
[TBL] [Abstract][Full Text] [Related]
36. Gene therapy for lysosomal storage disorders.
Ioannou YA; Enriquez A; Benjamin C
Expert Opin Biol Ther; 2003 Aug; 3(5):789-801. PubMed ID: 12880379
[TBL] [Abstract][Full Text] [Related]
37. Treatment options for lysosomal storage disorders: developing insights.
van Gelder CM; Vollebregt AA; Plug I; van der Ploeg AT; Reuser AJ
Expert Opin Pharmacother; 2012 Nov; 13(16):2281-99. PubMed ID: 23009070
[TBL] [Abstract][Full Text] [Related]
38. Similar therapeutic efficacy between a single administration of gene therapy and multiple administrations of recombinant enzyme in a mouse model of lysosomal storage disease.
Ferla R; Claudiani P; Cotugno G; Saccone P; De Leonibus E; Auricchio A
Hum Gene Ther; 2014 Jul; 25(7):609-18. PubMed ID: 24725025
[TBL] [Abstract][Full Text] [Related]
39. Lysosomal storage diseases: from pathophysiology to therapy.
Parenti G; Andria G; Ballabio A
Annu Rev Med; 2015; 66():471-86. PubMed ID: 25587658
[TBL] [Abstract][Full Text] [Related]
40. Lysosomal storage diseases: current therapies and future alternatives.
Leal AF; Espejo-Mojica AJ; Sánchez OF; Ramírez CM; Reyes LH; Cruz JC; Alméciga-Díaz CJ
J Mol Med (Berl); 2020 Jul; 98(7):931-946. PubMed ID: 32529345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
